Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9UJ70
UPID:
NAGK_HUMAN
Alternative names:
GlcNAc kinase; Muramyl dipeptide kinase; N-acetyl-D-mannosamine kinase
Alternative UPACC:
Q9UJ70; B4DLZ5; Q53HD5; Q6IA84; Q9BS29; Q9BVP0; Q9NV37
Background:
N-acetyl-D-glucosamine kinase, also known as GlcNAc kinase, plays a crucial role in cellular metabolism by converting GlcNAc into GlcNAc 6-phosphate. This enzyme is pivotal in the degradation pathway of N-glycolylneuraminic acid (Neu5Gc), a dietary component humans cannot synthesize. Additionally, it exhibits N-acetylmannosamine (ManNAc) kinase activity and is involved in innate immunity by catalyzing the phosphorylation of muramyl dipeptide, enhancing bacterial detection.
Therapeutic significance:
Understanding the role of N-acetyl-D-glucosamine kinase could open doors to potential therapeutic strategies. Its involvement in innate immunity and metabolic pathways underscores its potential as a target for developing treatments aimed at enhancing disease resistance and correcting metabolic disorders.